COSTANTE, GIUSEPPE
COSTANTE, GIUSEPPE
Dipartimento di Scienze della Salute
A case of anaplastic Diffuse Large B-Cell Thyroid Lymphoma: unique immunophenotype and unusual clinical presentation
2010-01-01 Bruno, R; Giannasio, P; Poggiaspalla, M; Carbone, A; Bellitti, P; Costante, G; Russo, D.
A hyperfunctioning Hurtle cell thyroid carcinoma with a mutation in the thyrotropin receptor
1997-01-01 Russo, D.; Arturi, F; Chiefari, E.; Wong, M. G.; Crocetti, U.; Costante, G.; Clark, O. H.; Filetti, S.
A novel de novo germ-line V292M mutation in the extracellular region of RET in a patient with phaeochromocytoma and medullary thyroid carcinoma: Functional characterization
2010-01-01 Castellone, Md; Verrienti, A; Rao, Dm; Sponziello, M; Fabbro, D; Muthu, M; Durante, C; Maranghi, M; Damante, G; Pizzolitto, S; Costante, G; Russo, D; Santoro, M; Filetti, S
A novel de novo germ-line V292M mutation in the extracellular region of RET in a patient with pheochromocytoma and medullary thyroid carcinoma: Functional characterization
2010-01-01 Castellone, Md; Verrienti, A; Rao, Dm; Sponziello, M; Fabbro, D; Muthu, M; Durante, C; Maranghi, M; Damante, G; Pizzolitto, S; Costante, G; Russo, D.; Santoro, M; Filetti, S
A novel double mutation val648ile and val804leu of ret proto-oncogene in multiple endocrine neoplasia type 2
2015-01-01 Verrienti, A; Carbone, A; Bellitti, P; Fabiano, Mc; DE ROSE, Rf; Maranghi, M; Lucia, P; Durante, C; Rosignolo, F; Pecce, V; Sponziello, M; Puppin, C; Costante, G; Bruno, R
A Val 677 activating mutation of the Thyrotropin receptor in a Hürthle cell thyroid carcinoma associated with thyrotoxicosis
1999-01-01 Russo, D.; Wong, Mg; Costante, G; Chiefari, E; Treseler, Pa
A Val677 activating mutation of the thyrotropin receptor in a Hurtle cell thyroid carcinoma associated with thyrotossicosis
1999-01-01 Russo, D.; Wong, M. G.; Costante, G.; Chiefari, E.; Treseler, P. A.; Arturi, F; Filetti, S.; Clark, O. H.
A Val677 activating mutation of the thyrotropin receptor in a Hürtle cell thyroid carcinoma associated with thyrotoxicosis
1999-01-01 Russo, D; Wong, M. G.; Costante, G; Chiefari, E; Treseler, P. A.; Arturi, F; Filetti, S; Clark, O
Absence of circulating desialylated thyroxine-binding globulin in patients wiht hepatobiliary disease
1985-01-01 Costante, G.; Sand, G.; Reding, P.; Glinoer, D.
Absence of circulating desialylated thyroxine-binding globulin in patients with hepatobiliary disease
1985-01-01 Costante, G; Sand, G; Reding, P; Glinoer, D
Alcune prospettive per la medicina clinica. La biologia molecolare
1992-01-01 Buzzetti, R; Costante, G; Pozzilli, P
Algoritmo diagnostico delle malattie tiroidee
2003-01-01 Costante, G; Filetti, S
Amiodarone
1987-01-01 Veltri, E. P.; Nitsch, J.; Luderitz, B.; Enia, G.; Catalano, C.; Zoccali, C.; Maggiore, Q.; Costante, G.; Martino, E.; Braverman, L. E.; Mariotti, S.; Bartalena, L.; Aghini-Lombardi, F.; Pinchera, A.; Promisloff, R. A.; Lenchner, G.; Cichelli, A.; Aaronson, G.; Wendell, G.; Segal, S.; Mason, J. W.
Amiodarone (letter)
1987-01-01 Enia, G; Catalano, C; Zoccali, C; Costante, G
An activating mutation in the thyrotropin receptor causing thyrotoxicosis in a Hurtle cell thyroid carcinoma
1997-01-01 Arturi, F; Wong, M. G.; Russo, D.; Crocetti, U.; Costante, G.; Filetti, S.; Clark, O. H.
Anaplastic thyroid carcinoma: advances in molecular profiling and targeted therapy
2023-01-01 Jungels, Christiane; Pita, Jaime Miguel; Costante, Giuseppe
Autoantibody-mediated capture and presentation of autoantigen to T cells via the Fc epsilon receptor by an autoantibody Fab converted to IgE
1996-01-01 Guo, J.; Quarantino, S.; Jaume, J. C.; Costante, G; Londei, M.; Mclachlan, S.; Rapoport, B.
Autoantibody-mediated capture and presentation of autoantigen to T cells via the Fcε receptor by a recombinant human autoantibody Fab converted to IgE
1996-01-01 Guo, J.; Quaratino, S.; Jaume, J. C.; Costante, G.; Londei, M.; Mclachlan, S. M.; Rapoport, B.
BRAF V600E and risk stratification of thyroid microcarcinoma: a multicenter pathological and clinical study
2015-01-01 Tallini, G; DE BIASE, D; Durante, C; Acquaviva, G; Bisceglia, M; Bruno, R; BACCHI REGGIANI, Ml; Casadei, Gp; Costante, G; Cremonini, N; Lamartina, L; Meringolo, D; Nardi, F; Pession, A; Rhoden, Kj; Ronga, G; Torlontano, M; Verrienti, A; Visani, M; Filetti, S
Calcitonin as a biomarker of C cell disease: recent achievements and current challenges
2020-01-01 Costante, G.; Meringolo, D.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A case of anaplastic Diffuse Large B-Cell Thyroid Lymphoma: unique immunophenotype and unusual clinical presentation | 1-gen-2010 | Bruno, R; Giannasio, P; Poggiaspalla, M; Carbone, A; Bellitti, P; Costante, G; Russo, D. | |
| A hyperfunctioning Hurtle cell thyroid carcinoma with a mutation in the thyrotropin receptor | 1-gen-1997 | Russo, D.; Arturi, F; Chiefari, E.; Wong, M. G.; Crocetti, U.; Costante, G.; Clark, O. H.; Filetti, S. | |
| A novel de novo germ-line V292M mutation in the extracellular region of RET in a patient with phaeochromocytoma and medullary thyroid carcinoma: Functional characterization | 1-gen-2010 | Castellone, Md; Verrienti, A; Rao, Dm; Sponziello, M; Fabbro, D; Muthu, M; Durante, C; Maranghi, M; Damante, G; Pizzolitto, S; Costante, G; Russo, D; Santoro, M; Filetti, S | |
| A novel de novo germ-line V292M mutation in the extracellular region of RET in a patient with pheochromocytoma and medullary thyroid carcinoma: Functional characterization | 1-gen-2010 | Castellone, Md; Verrienti, A; Rao, Dm; Sponziello, M; Fabbro, D; Muthu, M; Durante, C; Maranghi, M; Damante, G; Pizzolitto, S; Costante, G; Russo, D.; Santoro, M; Filetti, S | |
| A novel double mutation val648ile and val804leu of ret proto-oncogene in multiple endocrine neoplasia type 2 | 1-gen-2015 | Verrienti, A; Carbone, A; Bellitti, P; Fabiano, Mc; DE ROSE, Rf; Maranghi, M; Lucia, P; Durante, C; Rosignolo, F; Pecce, V; Sponziello, M; Puppin, C; Costante, G; Bruno, R | |
| A Val 677 activating mutation of the Thyrotropin receptor in a Hürthle cell thyroid carcinoma associated with thyrotoxicosis | 1-gen-1999 | Russo, D.; Wong, Mg; Costante, G; Chiefari, E; Treseler, Pa | |
| A Val677 activating mutation of the thyrotropin receptor in a Hurtle cell thyroid carcinoma associated with thyrotossicosis | 1-gen-1999 | Russo, D.; Wong, M. G.; Costante, G.; Chiefari, E.; Treseler, P. A.; Arturi, F; Filetti, S.; Clark, O. H. | |
| A Val677 activating mutation of the thyrotropin receptor in a Hürtle cell thyroid carcinoma associated with thyrotoxicosis | 1-gen-1999 | Russo, D; Wong, M. G.; Costante, G; Chiefari, E; Treseler, P. A.; Arturi, F; Filetti, S; Clark, O | |
| Absence of circulating desialylated thyroxine-binding globulin in patients wiht hepatobiliary disease | 1-gen-1985 | Costante, G.; Sand, G.; Reding, P.; Glinoer, D. | |
| Absence of circulating desialylated thyroxine-binding globulin in patients with hepatobiliary disease | 1-gen-1985 | Costante, G; Sand, G; Reding, P; Glinoer, D | |
| Alcune prospettive per la medicina clinica. La biologia molecolare | 1-gen-1992 | Buzzetti, R; Costante, G; Pozzilli, P | |
| Algoritmo diagnostico delle malattie tiroidee | 1-gen-2003 | Costante, G; Filetti, S | |
| Amiodarone | 1-gen-1987 | Veltri, E. P.; Nitsch, J.; Luderitz, B.; Enia, G.; Catalano, C.; Zoccali, C.; Maggiore, Q.; Costante, G.; Martino, E.; Braverman, L. E.; Mariotti, S.; Bartalena, L.; Aghini-Lombardi, F.; Pinchera, A.; Promisloff, R. A.; Lenchner, G.; Cichelli, A.; Aaronson, G.; Wendell, G.; Segal, S.; Mason, J. W. | |
| Amiodarone (letter) | 1-gen-1987 | Enia, G; Catalano, C; Zoccali, C; Costante, G | |
| An activating mutation in the thyrotropin receptor causing thyrotoxicosis in a Hurtle cell thyroid carcinoma | 1-gen-1997 | Arturi, F; Wong, M. G.; Russo, D.; Crocetti, U.; Costante, G.; Filetti, S.; Clark, O. H. | |
| Anaplastic thyroid carcinoma: advances in molecular profiling and targeted therapy | 1-gen-2023 | Jungels, Christiane; Pita, Jaime Miguel; Costante, Giuseppe | |
| Autoantibody-mediated capture and presentation of autoantigen to T cells via the Fc epsilon receptor by an autoantibody Fab converted to IgE | 1-gen-1996 | Guo, J.; Quarantino, S.; Jaume, J. C.; Costante, G; Londei, M.; Mclachlan, S.; Rapoport, B. | |
| Autoantibody-mediated capture and presentation of autoantigen to T cells via the Fcε receptor by a recombinant human autoantibody Fab converted to IgE | 1-gen-1996 | Guo, J.; Quaratino, S.; Jaume, J. C.; Costante, G.; Londei, M.; Mclachlan, S. M.; Rapoport, B. | |
| BRAF V600E and risk stratification of thyroid microcarcinoma: a multicenter pathological and clinical study | 1-gen-2015 | Tallini, G; DE BIASE, D; Durante, C; Acquaviva, G; Bisceglia, M; Bruno, R; BACCHI REGGIANI, Ml; Casadei, Gp; Costante, G; Cremonini, N; Lamartina, L; Meringolo, D; Nardi, F; Pession, A; Rhoden, Kj; Ronga, G; Torlontano, M; Verrienti, A; Visani, M; Filetti, S | |
| Calcitonin as a biomarker of C cell disease: recent achievements and current challenges | 1-gen-2020 | Costante, G.; Meringolo, D. |